| 1. | EXECUTIVE SUMMARY |
| 1.1. | Glossary of terms |
| 1.2. | What is industrial biomanufacturing? |
| 1.3. | Industrial Biomanufacturing 2027-2037: Scope |
| 1.4. | Market trends and drivers in industrial biomanufacturing (1/2) |
| 1.5. | Market trends and drivers in industrial biomanufacturing (2/2) |
| 1.6. | Synthetic biology as applied to industrial biomanufacturing |
| 1.7. | Technology trends in industrial biomanufacturing |
| 1.8. | Overview of alternative feedstocks for industrial biomanufacturing |
| 1.9. | Major market challenges for industrial biomanufacturing |
| 1.10. | Technical challenges facing industrial biomanufacturing |
| 1.11. | Products derived from industrial biomanufacturing: Overview |
| 1.12. | Molecules that can be produced through industrial biomanufacturing |
| 1.13. | Molecules that can be produced through industrial biomanufacturing |
| 1.14. | Company landscape in industrial biomanufacturing (1/2) |
| 1.15. | Company landscape in industrial biomanufacturing (2/2) |
| 1.16. | Next-generation fuels through industrial biomanufacturing |
| 1.17. | Bioplastics through industrial biomanufacturing |
| 1.18. | Navigating biobased polymers from monosaccharides |
| 1.19. | Common bioplastics and polymer precursors synthesized via industrial biomanufacturing |
| 1.20. | Status of molecules produced through industrial biomanufacturing |
| 1.21. | Industrial biomanufacturing global capacity forecast 2027-2037 |
| 1.22. | Industrial biomanufacturing market share by molecule 2027-2037 |
| 1.23. | IDTechEx circular bioeconomy research |
| 1.24. | Company profiles |
| 1.25. | Access more with an IDTechEx subscription |
| 2. | INTRODUCTION |
| 2.1. | Glossary of terms |
| 2.2. | Biotechnology application |
| 2.3. | What is industrial biomanufacturing? |
| 2.4. | The bioeconomy and industrial biomanufacturing |
| 2.5. | Industrial Biomanufacturing 2027-2037: Scope |
| 2.6. | Molecules that can be produced through industrial biomanufacturing |
| 2.7. | Molecules that can be produced through industrial biomanufacturing |
| 3. | MARKET ANALYSIS |
| 3.1. | Market drivers for industrial biomanufacturing |
| 3.2. | Market drivers: Demand for biobased products |
| 3.3. | Overview of bioplastics regulations around the world (1/2) |
| 3.4. | Overview of bioplastics regulations around the world (2/2) |
| 3.5. | Proposed EU biobased content targets for plastic packaging |
| 3.6. | Regulations are driving strong interest in biodegradable plastics in China |
| 3.7. | US government support of biotechnology |
| 3.8. | Other policy support for biomanufacturing |
| 3.9. | Carbon taxes as a market driver |
| 3.10. | Economic viability of industrial biomanufacturing |
| 3.11. | Factors affecting the economic viability of industrial biomanufacturing projects |
| 3.12. | Effect of the price of Brent crude on biobased products |
| 3.13. | The green premium |
| 3.14. | The effect of biomass feedstock prices on the bioplastics market |
| 3.15. | Effect of cell factory on cost |
| 3.16. | Identifying the chemicals with the most potential to become biobased based on price |
| 3.17. | How scale-up affects cost |
| 3.18. | Zymergen: Case study on economics of synthetic biology |
| 3.19. | Case study: LanzaTech |
| 3.20. | Case study: Solazyme |
| 3.21. | Synthetic biology: Shift from commodity products to lower volume, high value markets |
| 3.22. | Major market challenges for industrial biomanufacturing |
| 3.23. | Players and Regional Landscape |
| 3.24. | Production capacity of chemicals from biomanufacturing by region 2027 |
| 3.25. | Regional analysis: Drivers and restraints for biomanufacturing production and demand by region |
| 3.26. | Regional analysis: Location of R&D vs production |
| 3.27. | Regional analysis: Biomanufacturing |
| 3.28. | Regional analysis: Production capacity by region |
| 3.29. | Players: Synthetic biology tools and platforms |
| 3.30. | Players: Vertically integrated biomanufacturing technology provider |
| 3.31. | Emerging players segmented by molecule (1/2) |
| 3.32. | Emerging players segmented by molecule (2/2) |
| 3.33. | Overview of major chemicals and materials companies involved in industrial biomanufacturing (1/2) |
| 3.34. | Overview of major chemicals and materials companies involved in industrial biomanufacturing (2/2) |
| 4. | CELL FACTORIES FOR INDUSTRIAL BIOMANUFACTURING |
| 4.1. | Cell factories for biomanufacturing: Factors to consider |
| 4.2. | Cell factories for biomanufacturing: A range of organisms |
| 4.3. | Escherichia coli (E. coli) |
| 4.4. | Corynebacterium glutamicum (C. glutamicum) |
| 4.5. | Bacillus subtilis (B. subtilis) |
| 4.6. | Saccharomyces cerevisiae (S. cerevisiae) |
| 4.7. | Yarrowia lipolytica (Y. lipolytica) |
| 4.8. | Microorganisms used in different biomanufacturing processes |
| 4.9. | Non-model organisms for industrial biomanufacturing |
| 5. | TECHNOLOGY DEVELOPMENTS |
| 5.1. | Synthetic Biology |
| 5.1.1. | Synthetic biology: The design and engineering of biological systems |
| 5.1.2. | Synthetic biology: Manipulating the central dogma |
| 5.1.3. | The vast scope of synthetic biology |
| 5.1.4. | The process of synthetic biology: Design, build and test |
| 5.1.5. | Synthetic biology: Why now? |
| 5.1.6. | Synthetic biology: From pharmaceuticals to consumer products |
| 5.1.7. | Synthetic biology: Disrupting existing chemicals supply chains |
| 5.1.8. | Synthetic biology: Drivers and barriers for adoption |
| 5.1.9. | Synthetic biology as applied to industrial biomanufacturing |
| 5.1.10. | Tools and Techniques of Synthetic Biology |
| 5.1.11. | Tools and techniques of synthetic biology: Overview |
| 5.1.12. | DNA synthesis |
| 5.1.13. | Introduction to CRISPR-Cas9 |
| 5.1.14. | CRISPR-Cas9: A bacterial immune system |
| 5.1.15. | CRISPR-Cas9's importance to synthetic biology |
| 5.1.16. | Strain construction and optimization |
| 5.1.17. | Protein/enzyme engineering |
| 5.1.18. | Computer-aided design |
| 5.1.19. | Commercial examples of engineered proteins in industrial applications |
| 5.1.20. | Synergy between synthetic biology and metabolic engineering |
| 5.1.21. | Framework for developing industrial microbial strains |
| 5.1.22. | The problem with scale |
| 5.2. | Cell-free biomanufacturing |
| 5.2.1. | Introduction to cell-free systems |
| 5.2.2. | Cell-free versus cell-based systems |
| 5.2.3. | Cell-free systems in the context of industrial biomanufacturing |
| 5.2.4. | Cell-free systems for industrial biomanufacturing |
| 5.2.5. | Commercial implementation of cell-free systems: Solugen |
| 5.2.6. | Startups pursuing cell-free systems for industrial biomanufacturing (1/2) |
| 5.2.7. | Startups pursuing cell-free systems for industrial biomanufacturing (2/2) |
| 5.2.8. | Immobilized enzymes in industrial biomanufacturing (1/2) |
| 5.2.9. | Immobilized catalysts in industrial biomanufacturing (2/2) |
| 5.3. | Improvement of Biomanufacturing Processes |
| 5.3.1. | Continuous vs batch biomanufacturing |
| 5.3.2. | Continuous perfusion bioreactors |
| 5.3.3. | Benefits and challenges of continuous biomanufacturing |
| 5.3.4. | Continuous vs. batch biomanufacturing: Key fermentation parameter comparison |
| 5.3.5. | Continuous fermentation: DAB.bio |
| 5.3.6. | Simultaneous saccharification and fermentation (SSF) |
| 5.3.7. | Sterility-free fermentation |
| 5.3.8. | Downstream processing (DSP) improvements (1/2) |
| 5.3.9. | Downstream processing (DSP) improvements (2/2) |
| 5.3.10. | Tangential flow filtration (TFF) in downstream bioprocessing |
| 5.3.11. | Hybrid biotechnological-chemical approaches |
| 5.3.12. | Process intensification and high-cell-density fermentation |
| 5.4. | Automation and AI for Biomanufacturing |
| 5.4.1. | Robotics: Enabling hands-free and high throughput science |
| 5.4.2. | Robotic cloud laboratories |
| 5.4.3. | Automating organism design and closing the loop |
| 5.4.4. | Machine learning de novo protein prediction |
| 5.4.5. | AI-driven protein/enzyme design companies |
| 5.4.6. | Machine learning to improve biomanufacturing processes |
| 5.4.7. | AI-driven fermentation platform companies |
| 5.4.8. | Overview of machine learning-based improvements for biomanufacturing |
| 5.5. | Industrial Biomanufacturing for Sustainability |
| 5.5.1. | Industrial biomanufacturing as a sustainable technology |
| 5.5.2. | Routes for carbon capture in industrial biomanufacturing |
| 5.5.3. | Autotrophic bacteria for carbon capture through biomanufacturing |
| 5.6. | Next Generation Feedstocks for Biomanufacturing |
| 5.6.1. | Why use alternative feedstocks for industrial biomanufacturing? |
| 5.6.2. | Food, land, and water competition |
| 5.6.3. | C1 feedstocks: Metabolic pathways |
| 5.6.4. | C1 feedstocks: Economic benefits |
| 5.6.5. | C1 feedstocks: Challenges |
| 5.6.6. | Non-methane C1 feedstocks |
| 5.6.7. | C1 feedstocks: Products |
| 5.6.8. | C1 feedstocks: Gas fermentation |
| 5.6.9. | C2 feedstocks |
| 5.6.10. | C2 feedstocks: Products segmented by feedstock |
| 5.6.11. | C1 and C2 feedstocks: Commercial activity (1/2) |
| 5.6.12. | C1 and C2 feedstocks: Commercial activity (2/2) |
| 5.6.13. | Lignocellulosic biomass feedstocks |
| 5.6.14. | Lignocellulosic biomass feedstocks: Challenges |
| 5.6.15. | Lignocellulosic biomass feedstocks: Challenges |
| 5.6.16. | Lignocellulosic biomass feedstocks: Products |
| 5.6.17. | Lignocellulosic feedstocks: Commercial activity |
| 6. | BLUE BIOTECHNOLOGY |
| 6.1. | What is blue biotechnology? |
| 6.2. | Main biocatalysts of blue biotechnology: Cyanobacteria and algae |
| 6.3. | Cyanobacteria |
| 6.4. | Algae |
| 6.5. | Key drivers and challenges for blue biotechnology |
| 6.6. | Selected startups in blue biotechnology |
| 7. | PRODUCTS DERIVED FROM INDUSTRIAL BIOMANUFACTURING |
| 7.1.1. | Products derived from industrial biomanufacturing: Overview |
| 7.2. | Fuels |
| 7.2.1. | Biofuel generations: Conventional & advanced biofuels |
| 7.2.2. | Biofuel generations: Feedstocks |
| 7.2.3. | Industrial biomanufacturing for biofuel production |
| 7.2.4. | Biofuel generations: Biomanufacturing process |
| 7.2.5. | Metabolic pathways to biofuels |
| 7.2.6. | Overview of 1st generation bioethanol production |
| 7.2.7. | Next-generation bioethanol |
| 7.2.8. | Next generation bioethanol: Barriers |
| 7.2.9. | Next generation bioethanol production overview |
| 7.2.10. | Diesel from biomanufacturing pathways |
| 7.2.11. | Farnesene: A case study of Amyris |
| 7.2.12. | n-Butanol |
| 7.2.13. | Isobutanol |
| 7.2.14. | Methanol |
| 7.2.15. | Blue biotechnology in biofuel production |
| 7.2.16. | Blue biotechnology in biodiesel production |
| 7.2.17. | Blue biotechnology in bioethanol production |
| 7.2.18. | Blue biotechnology for biofuel production: Key challenges for commercial viability |
| 7.2.19. | Blue biotechnology for biofuel production: Commercial activity by US oil producers |
| 7.2.20. | Blue biotechnology for biofuel production: Commercial activity by non-US oil producers |
| 7.2.21. | Blue biotechnology for biofuel production: List of current and former players |
| 7.2.22. | Blue biotechnology for biofuel production: List of current and former players |
| 7.2.23. | Blue biotechnology for biofuel production: List of current and former players |
| 7.3. | Plastics and Textiles |
| 7.3.1. | Introduction to bioplastics |
| 7.3.2. | Production of bioplastics through industrial biomanufacturing |
| 7.3.3. | Navigating biobased polymers from monosaccharides |
| 7.3.4. | Common bioplastics and polymer precursors synthesized via industrial biomanufacturing |
| 7.3.5. | Bioplastics 2026-2036 |
| 7.3.6. | Lactic Acid and Polylactic Acid (PLA) |
| 7.3.7. | Lactic acid (C3H6O3) |
| 7.3.8. | Lactic acid: Microbial fermentation and chemical synthesis |
| 7.3.9. | Optimal lactic acid bacteria strains for fermentation |
| 7.3.10. | Engineering yeast strains for lactic acid fermentation |
| 7.3.11. | Fermentation, recovery and purification |
| 7.3.12. | What is polylactic acid? |
| 7.3.13. | Production of PLA |
| 7.3.14. | PLA production process |
| 7.3.15. | Polylactic acid: A SWOT analysis |
| 7.3.16. | Molecules for Other Biobased Synthetic Polyesters |
| 7.3.17. | The range of available bio-based polyesters |
| 7.3.18. | Monoethylene glycol (MEG) |
| 7.3.19. | Polyethylene terephthalate (PET) |
| 7.3.20. | Biobased MEG: Monomer production |
| 7.3.21. | Biobased MEG: Industry landscape |
| 7.3.22. | Biobased MEG: Industry landscape |
| 7.3.23. | Propylene glycol (PG) or 1,2-propanediol |
| 7.3.24. | 1,3-Propanediol (1,3-PDO) |
| 7.3.25. | Biobased 1,3-PDO and PTT: Monomer production |
| 7.3.26. | Biobased 1,3-PDO and PTT: Polymer applications |
| 7.3.27. | 2,3-Butanediol (2,3-BDO) |
| 7.3.28. | 1,4-Butanediol (1,4-BDO) |
| 7.3.29. | Biobased 1,4-BDO: Monomer production |
| 7.3.30. | Biobased 1,4-BDO technology licensed from Geno |
| 7.3.31. | Biobased BDO and PBT: Polymer applications |
| 7.3.32. | Succinic acid |
| 7.3.33. | Biobased succinic acid: Monomer production |
| 7.3.34. | Biobased succinic acid and PBS: Polymer applications |
| 7.3.35. | Biobased succinic acid: Project status |
| 7.3.36. | 2,5-furandicarboxylic acid (FDCA) |
| 7.3.37. | Biobased FDCA: Monomer production |
| 7.3.38. | Polyethylene furanoate (PEF) |
| 7.3.39. | Biobased FDCA and PEF: Polymer applications |
| 7.3.40. | Molecules for Other Biobased Synthetic Polymers |
| 7.3.41. | Biobased ethanol as a precursor to ethylene |
| 7.3.42. | Biomanufacturing of ethylene |
| 7.3.43. | Biobased polyolefins: Challenges and opportunities |
| 7.3.44. | Braskem: "I'm Green" biobased polyethylene |
| 7.3.45. | Biomanufacturing of propylene precursors |
| 7.3.46. | Biosynthetic pathways to polyamides |
| 7.3.47. | C6: Adipic acid, hexamethylenediamine, and caprolactam by Geno |
| 7.3.48. | Biosynthesis of Adipic Acid by Toray |
| 7.3.49. | C10: Sebacic acid |
| 7.3.50. | C12: Dodecanedioic acid |
| 7.3.51. | 1,5-Pentanediamine (PDA) |
| 7.3.52. | Covestro: PDI and Desmodur eco aliphatic polyisocyanate |
| 7.3.53. | Cathay Industrial Biotech: TERRYL and ECOPENT biobased polyamides |
| 7.3.54. | 1,3-Butadiene |
| 7.3.55. | Status of biomanufacturing-derived butadiene projects |
| 7.3.56. | Isoprene |
| 7.3.57. | Isobutene (isobutylene) |
| 7.3.58. | Naturally Occurring Biobased Polymers: Polyhydroxyalkanoates (PHAs) |
| 7.3.59. | Introduction to polyhydroxyalkanoates |
| 7.3.60. | Biosynthetic pathways to PHAs |
| 7.3.61. | Fermentation, recovery and purification of PHAs |
| 7.3.62. | Key commercial PHAs and microstructures |
| 7.3.63. | PHB, PHBV, and PHBB |
| 7.3.64. | Short and medium chain-length PHAs |
| 7.3.65. | PHA used in elastomers |
| 7.3.66. | Types of PHAs |
| 7.3.67. | Applications of PHAs |
| 7.3.68. | Opportunities in PHAs |
| 7.3.69. | Reducing the cost of PHA production |
| 7.3.70. | Risks in PHAs |
| 7.3.71. | Case Study: Danimer Scientific bankruptcy |
| 7.3.72. | PHAs: A SWOT analysis |
| 7.3.73. | PHAs are only made in small quantities |
| 7.3.74. | PHA production facilities |
| 7.3.75. | PHA: Bio-based and biodegradable certifications |
| 7.3.76. | Suppliers of PHAs |
| 7.3.77. | PHA outlook |
| 7.3.78. | Other textiles produced through industrial biomanufacturing |
| 7.3.79. | Spider silk |
| 7.3.80. | Collagen |
| 7.3.81. | Mycelium |
| 7.4. | Additives and Precursors |
| 7.4.1. | Acetone |
| 7.4.2. | Acrylic acid |
| 7.4.3. | Itaconic acid |
| 7.4.4. | Malonic acid |
| 7.4.5. | Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs) |
| 7.4.6. | Short chain fatty acids and medium chain fatty acids (SCFAs & MCFAs) |
| 7.4.7. | Short chain fatty acids: Acetic acid |
| 7.4.8. | Other organic acids and aldehydes |
| 7.4.9. | Triglycerides |
| 7.5. | Other Products Derived from Industrial Biomanufacturing |
| 7.5.1. | Bacterial cellulose |
| 7.5.2. | Overview of vitamins and amino acids produced through industrial biomanufacturing |
| 7.5.3. | Overview of industrial biomanufacturing for cosmetics |
| 7.5.4. | Enzymes for detergents |
| 7.5.5. | Enzymes for onward use: Novonesis |
| 7.5.6. | Biosurfactants |
| 7.5.7. | Cement alternatives from biomanufacturing: BioMason |
| 7.5.8. | Precision fermentation: Definition and scope |
| 8. | FORECASTS FOR INDUSTRIAL BIOMANUFACTURING |
| 8.1. | Forecast methodology |
| 8.2. | Industrial biomanufacturing global capacity forecast 2027-2037 |
| 8.3. | Industrial biomanufacturing market share by molecule 2027-2037 |
| 8.4. | Industrial biomanufacturing global capacity forecast 2027-2037: Discussion |
| 8.5. | Industrial biomanufacturing global capacity forecast 2027-2037: Discussion |
| 8.6. | Industrial biomanufacturing global capacity forecast 2026-2037: Discussion |
| 8.7. | Industrial biomanufacturing global capacity forecast 2027-2037: Discussion |
| 8.8. | Industrial biomanufacturing global capacity forecast 2027-2037: Discussion |
| 9. | COMPANY PROFILES |
| 9.1. | Afyren |
| 9.2. | Arzeda |
| 9.3. | Biomason |
| 9.4. | Bolt Threads |
| 9.5. | Braskem Bioplastics |
| 9.6. | CarbonBridge |
| 9.7. | Cathay Industrial Biotech |
| 9.8. | Celtic Renewables |
| 9.9. | Chaincraft |
| 9.10. | CyanoCapture |
| 9.11. | Ecovative Forager |
| 9.12. | Enginzyme |
| 9.13. | Enzymaster |
| 9.14. | Geno: 1,4-Butanediol |
| 9.15. | Geno: C6 Nylon Precursors |
| 9.16. | Industrial Microbes |
| 9.17. | Kraig Biocraft Laboratories |
| 9.18. | LanzaTech |
| 9.19. | New Energy Blue |
| 9.20. | Novozymes (now Novonesis) |
| 9.21. | Q Power |
| 9.22. | Solugen |
| 9.23. | Spiber |
| 9.24. | 17Cicada |
| 9.25. | Henan Techuang Biotechnology |
| 9.26. | Huitong Biomaterials |
| 9.27. | NatureWorks |
| 9.28. | Teijin Frontier: PLA |
| 9.29. | TotalEnergies Corbion |
| 9.30. | Biotic Circular Technologies |
| 9.31. | Bluepha |
| 9.32. | CJ Biomaterials |
| 9.33. | Danimer Scientific |
| 9.34. | Fortum: INGA Plastic |
| 9.35. | Kaneka: PHAs |
| 9.36. | Mango Materials |
| 9.37. | Newlight Technologies |
| 9.38. | Ourobio |
| 9.39. | Paques Biomaterials |
| 9.40. | Shellworks |